SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
By S. Pai, E. Cohen, Derrick Lin, G. Fountzilas, Edward S Kim, H. Mehlhorn, N. Basté, D. Clayburgh, Loren Lipworth, C. Resteghini and 10 more. 2019
Subfields: Immunology, Oncology, Otorhinolaryngology